INDOCO logo

Indoco Remedies Limited Stock Price

NSEI:INDOCO Community·₹23.8b Market Cap
  • 4 Narratives written by author
  • 0 Comments on narratives written by author
  • 18 Fair Values set on narratives written by author

INDOCO Share Price Performance

₹0
-322.00 (-100.00%)
₹380.00
Fair Value
₹0
-322.00 (-100.00%)
Price ₹0

INDOCO Community Narratives

ThewealthyinvestorbyDSAB·
Fair Value ₹380 31.1% undervalued intrinsic discount

Indoco Remedies Will Benefit from India's Healthcare Growth

0users have liked this narrative
0users have commented on this narrative
10users have followed this narrative
AnalystConsensusTarget·
Fair Value ₹260 0.6% overvalued intrinsic discount

Regulatory Challenges And Capacity Expansion Will Reshape Future Potential

0users have liked this narrative
0users have commented on this narrative
5users have followed this narrative
AnalystLowTarget·
Fair Value ₹207 26.4% overvalued intrinsic discount

US And EU Regulation Will Hamper Long-Term Profitability

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
₹207
26.4% overvalued intrinsic discount
AnalystLowTarget Fair Value
Revenue
13.87% p.a.
Profit Margin
7.95%
Future PE
15.41x
Price in 2028
₹300.65
₹260
0.6% overvalued intrinsic discount
Revenue
15.04% p.a.
Profit Margin
10.5%
Future PE
10.32x
Price in 2028
₹377.21

Trending Discussion

Updated Narratives

INDOCO logo

Indoco Remedies Will Benefit from India's Healthcare Growth

Fair Value: ₹380 31.1% undervalued intrinsic discount
10 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
INDOCO logo

Regulatory Challenges And Capacity Expansion Will Reshape Future Potential

Fair Value: ₹260 0.6% overvalued intrinsic discount
5 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
INDOCO logo

US And EU Regulation Will Hamper Long-Term Profitability

Fair Value: ₹207 26.4% overvalued intrinsic discount
0 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Undervalued with reasonable growth potential.

1 Risk
3 Rewards

Indoco Remedies Limited Key Details

₹17.3b

Revenue

₹5.6b

Cost of Revenue

₹11.7b

Gross Profit

₹12.8b

Other Expenses

-₹1.1b

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
-11.98
67.68%
-6.41%
96.3%
View Full Analysis

About INDOCO

Founded
1945
Employees
6000
CEO
Sundeep Bambolkar
WebsiteView website
www.indoco.com

Indoco Remedies Limited manufactures and markets formulations and active pharmaceutical ingredients in India and internationally. It offers products for gastrointestinal, anti-infectives, respiratory, stomatological, vitamins/minerals/nutrients, urological, ophthal/ontological, dermatology, pain/analgesic, cardiac, anti-diabetic, and gynaecological therapeutic areas. The company also provides branded generics comprising analgesic tablets and topical preparations; anti-hypertensive; protein supplements; multivitamin tablets and syrups; antibiotic tablets, syrups, and injectables; oral rehydration powders; antacids; and antihistaminic, anti-inflammatory drugs, etc. In addition, it provides analytical services, such as impurity profile, particle size analysis, polymorphism and compatibility studies, heavy metal analysis, extractables and leachables studies, lyophilization studies, reference and working standards, forced degradation studies, and chromatographic method development and validation services. Further, the company offers architectural design, lighting, mechanical and utility engineering, project and construction management, electrical, control system, piping, structural design, data transfer system, and process engineering. Additionally, it provides contract research services, such as custom chemical synthesis of molecules and intermediates; process chemistry research and development; non-infringing process designing and scale up; and analytical method development, validation, impurity characterization, and polymorphic studies, solutions, as well as intellectual property management. The company was formerly known as Indo Continental Trading Company. Indoco Remedies Limited was founded in 1945 and is based in Mumbai, India.

Recent INDOCO News & Updates

Recent updates

No updates